272 related articles for article (PubMed ID: 29188452)
1. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
2. Lnc-NTF3-5 promotes osteogenic differentiation of maxillary sinus membrane stem cells via sponging miR-93-3p.
Peng W; Zhu SX; Wang J; Chen LL; Weng JQ; Chen SL
Clin Implant Dent Relat Res; 2018 Apr; 20(2):110-121. PubMed ID: 29106055
[TBL] [Abstract][Full Text] [Related]
3. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.
Han SY; Lee KH; Kim YK
Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.
Park OJ; Kim J; Kim HY; Kwon Y; Yun CH; Han SH
Microb Pathog; 2019 Jan; 126():218-223. PubMed ID: 30414445
[TBL] [Abstract][Full Text] [Related]
6. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.
Li L; Sapkota M; Gao M; Choi H; Soh Y
Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.
Ohe JY; Kwon YD; Lee HW
Clin Oral Investig; 2012 Aug; 16(4):1153-9. PubMed ID: 21938481
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
9. Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.
Komatsu K; Shimada A; Shibata T; Wada S; Ideno H; Nakashima K; Amizuka N; Noda M; Nifuji A
J Endocrinol; 2013 Nov; 219(2):145-58. PubMed ID: 24096963
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways.
Peng Y; Liu Q; Xu D; Li K; Li H; Qiu L; Lin J
Cell Biol Int; 2021 May; 45(5):1015-1029. PubMed ID: 33404170
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of N-bisphosphonate in osteoblastic cells mitigated by non-N-bisphosphonate but not by sodium-dependent phosphate cotransporter inhibitor.
Baba TT; Miyazaki T; Ohara-Nemoto Y; Nemoto TK
Cell Biochem Funct; 2019 Aug; 37(6):400-407. PubMed ID: 31328801
[TBL] [Abstract][Full Text] [Related]
12. The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).
Pan B; Farrugia AN; To LB; Findlay DM; Green J; Lynch K; Zannettino AC
J Bone Miner Res; 2004 Jan; 19(1):147-54. PubMed ID: 14753746
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation.
Tseng HC; Kanayama K; Kaur K; Park SH; Park S; Kozlowska A; Sun S; McKenna CE; Nishimura I; Jewett A
Oncotarget; 2015 Aug; 6(24):20002-25. PubMed ID: 26343372
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
[TBL] [Abstract][Full Text] [Related]
15. Serial administration of rhBMP-2 and alendronate enhances the differentiation of osteoblasts.
Kim SH; Choi HJ; Yoon DS; Son CN
Int J Rheum Dis; 2021 Oct; 24(10):1266-1272. PubMed ID: 34324274
[TBL] [Abstract][Full Text] [Related]
16. Zoledronate inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclast differentiation via suppression of expression of nuclear factor of activated T-cell c1 and carbonic anhydrase 2.
Nakagawa T; Ohta K; Kubozono K; Ishida Y; Naruse T; Takechi M; Kamata N
Arch Oral Biol; 2015 Apr; 60(4):557-65. PubMed ID: 25601046
[TBL] [Abstract][Full Text] [Related]
17. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
[TBL] [Abstract][Full Text] [Related]
18. Effect of the combined use of enamel matrix derivative and atelocollagen sponge scaffold on osteoblastic differentiation of mouse induced pluripotent stem cells in vitro.
Hisanaga Y; Suzuki E; Aoki H; Sato M; Saito A; Saito A; Azuma T
J Periodontal Res; 2018 Apr; 53(2):240-249. PubMed ID: 29044527
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen Containing Bisphosphonates Impair the Release of Bone Homeostasis Mediators and Matrix Production by Human Primary Pre-Osteoblasts.
Giannasi C; Niada S; Farronato D; Lombardi G; Manfredi B; Farronato G; Brini AT
Int J Med Sci; 2019; 16(1):23-32. PubMed ID: 30662325
[TBL] [Abstract][Full Text] [Related]
20. Dioxins interfere with differentiation of osteoblasts and osteoclasts.
Korkalainen M; Kallio E; Olkku A; Nelo K; Ilvesaro J; Tuukkanen J; Mahonen A; Viluksela M
Bone; 2009 Jun; 44(6):1134-42. PubMed ID: 19264158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
